{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:54:47Z","timestamp":1787169287405,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40123-026-01392-3","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:31:37Z","timestamp":1778214697000},"page":"2033-2050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Randomized Double-Masked Study Evaluating Safety and Efficacy of a Novel Topical Cooling Device for Chronic Ocular Surface Pain"],"prefix":"10.1007","volume":"15","author":[{"given":"Anat","family":"Galor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rapuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Epitropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepinder","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Periman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie An","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chameen","family":"Samarawickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Stryjewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Stefater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bhindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-6656","authenticated-orcid":false,"given":"Cristos","family":"Ifantides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jtos.2022.08.005","volume":"26","author":"A Galor","year":"2022","unstructured":"Galor A, Hamrah P, Haque S, Attal N, Labetoulle M. Understanding chronic ocular surface pain: an unmet need for targeted drug therapy. Ocul Surf. 2022;26:148\u201356.","journal-title":"Ocul Surf"},{"issue":"3","key":"1392_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"C Belmonte","year":"2017","unstructured":"Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15(3):404\u201337.","journal-title":"Ocul Surf"},{"key":"1392_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","volume":"182","author":"KF Farrand","year":"2017","unstructured":"Farrand KF, Fridman M, Stillman I\u00d6, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18\u00a0years and older. Am J Ophthalmol. 2017;182:90\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1392_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/OPX.0b013e318181a947","volume":"85","author":"SE Moss","year":"2008","unstructured":"Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668\u201374.","journal-title":"Optom Vis Sci"},{"issue":"7","key":"1392_CR5","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1167\/iovs.16-19419","volume":"57","author":"KK Nichols","year":"2016","unstructured":"Nichols KK, Bacharach J, Holland E, et al. Impact of dry eye disease on work productivity, and patients\u2019 satisfaction with over-the-counter dry eye treatments. Invest Ophthalmol Vis Sci. 2016;57(7):2975\u201382.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1392_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2147\/OPTH.S233194","volume":"14","author":"DE White","year":"2020","unstructured":"White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A. Treatment satisfaction among patients using anti-inflammatory topical medications for dry eye disease. Clin Ophthalmol. 2020;14:875\u201383.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1392_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0181-5512(08)71431-1","volume":"31","author":"C Baudouin","year":"2008","unstructured":"Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, et al. Severe impairment of health-related quality of life in patients suffering from ocular surface diseases. J Fr Ophtalmol. 2008;31(4):369\u201378.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1392_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1167\/iovs.15-18133","volume":"57","author":"O Spierer","year":"2016","unstructured":"Spierer O, Felix ER, McClellan AL, et al. Corneal mechanical thresholds negatively associate with dry eye and ocular pain symptoms. Invest Ophthalmol Vis Sci. 2016;57(2):617\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1392_CR9","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/jid.2015.233","volume":"135","author":"L Garibyan","year":"2015","unstructured":"Garibyan L, Cornelissen L, Sipprell W, et al. Transient alterations of cutaneous sensory nerve function by noninvasive cryolipolysis. J Invest Dermatol. 2015;135(11):2623\u201331.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1392_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/ALN.0000000000003124","volume":"133","author":"L Garibyan","year":"2020","unstructured":"Garibyan L, Moradi Tuchayi S, Wang Y, et al. Neural selective cryoneurolysis with ice slurry injection in a rat model. Anesthesiol. 2020;133(1):185\u201394.","journal-title":"Anesthesiol"},{"issue":"4","key":"1392_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/eye.1994.98","volume":"8","author":"CK Chee","year":"1994","unstructured":"Chee CK, Snead MP, Scott JD. Cyclocryotherapy for chronic glaucoma after vitreoretinal surgery. Eye. 1994;8(4):414\u20138.","journal-title":"Eye"},{"issue":"1","key":"1392_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3341\/kjo.2015.29.1.47","volume":"29","author":"BS Kim","year":"2015","unstructured":"Kim BS, Kim YJ, Seo SW, Yoo JM, Kim SJ. Long-term results from cyclocryotherapy applied to the 3o\u2019clock and 9o\u2019clock positions in blind refractory glaucoma patients. Korean J Ophthalmol. 2015;29(1):47\u201352.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"1392_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjo.74.2.103","volume":"74","author":"MT Benson","year":"1990","unstructured":"Benson MT, Nelson ME. Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol. 1990;74(2):103\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1392_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bjophthalmol-2016-309658","volume":"101","author":"AM Crane","year":"2017","unstructured":"Crane AM, Feuer W, Felix ER, et al. Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain. Br J Ophthalmol. 2017;101(9):1238\u201343. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309658.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"1392_CR15","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.ophtha.2017.08.004","volume":"124","author":"G Dieckmann","year":"2017","unstructured":"Dieckmann G, Goyal S, Hamrah P. Neuropathic corneal pain: approaches for management. Ophthalmology. 2017;124(11):S34-47.","journal-title":"Ophthalmology"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12886-020-01733-1","volume":"20","author":"J Kim","year":"2020","unstructured":"Kim J, Yoon HJ, You IC, Ko BY, Yoon KC. Clinical characteristics of dry eye with ocular neuropathic pain features: comparison according to the types of sensitization based on the Ocular Pain Assessment Survey. BMC Ophthalmol. 2020;20:455.","journal-title":"BMC Ophthalmol"},{"issue":"1-2","key":"1392_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","volume":"31","author":"P Hamrah","year":"2016","unstructured":"Hamrah P, Goyal S. Understanding neuropathic corneal pain\u2014gaps and current therapeutic approaches. Semin Ophthalmol. 2016;31(1\u20132):59\u201370.","journal-title":"Semin Ophthalmol"},{"key":"1392_CR18","unstructured":"US Food and Drug Administration. Investigational Device Exemptions (IDEs) for early feasibility medical device clinical studies, including certain First in Human (FIH) studies. Guidance for Industry and FDA Staff. October 2013. https:\/\/www.fda.gov\/media\/81784\/download. Accessed Apr 30, 2025."},{"key":"1392_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomized pilot and feasibility trials. BMJ. 2016;355:i5239.","journal-title":"BMJ"},{"issue":"5","key":"1392_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000079478","volume":"218","author":"AM Roszkowska","year":"2004","unstructured":"Roszkowska AM, Colosi P, Ferreri FM, Galasso S. Age-related modifications of corneal sensitivity. Ophthalmologica. 2004;218(5):350\u20135.","journal-title":"Ophthalmologica"},{"key":"1392_CR21","unstructured":"Holland EJ, Kim T, Nichols KK et al. Safety and efficacy of KPI-121 ophthalmic suspension 0.25% for dry eye disease in three phase three randomized controlled trials. Abstract presented at: AAO Virtual Meeting; November 13\u201315, 2020. Abstract 30064820."},{"issue":"3","key":"1392_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/cmi.cmi_24_20","volume":"18","author":"S Kotak","year":"2020","unstructured":"Kotak S, Christina M, Selvin SS. Establishing the normal range of corneal sensitivity in an Indian population using the Cochet\u2013Bonnet esthesiometer. Curr Med Issues. 2020;18(3):170\u20134.","journal-title":"Curr Med Issues"},{"key":"1392_CR23","first-page":"262","volume":"57","author":"W Booranapong","year":"2005","unstructured":"Booranapong W, Tanthuvanit P, Suwannik A. Corneal sensation in the normal Thai population. Siriraj Med J. 2005;57:262\u20135.","journal-title":"Siriraj Med J"},{"key":"1392_CR24","first-page":"240","volume":"16","author":"M Millodot","year":"1977","unstructured":"Millodot M. The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci. 1977;16:240\u20132.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1392_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-025-00862-9","volume":"9","author":"A Findley","year":"2025","unstructured":"Findley A, Sloesen BJ, Hodson N, et al. Psychometric validation of the Chronic Ocular Pain Questionnaire (COP-Q). J Patient Rep Outcomes. 2025;9(1):32. https:\/\/doi.org\/10.1186\/s41687-025-00862-9.","journal-title":"J Patient Rep Outcomes"},{"issue":"7","key":"1392_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ophtha.2016.03.006","volume":"123","author":"Y Qazi","year":"2016","unstructured":"Qazi Y, Hurwitz S, Khan S, Jurkunas UV, Dana R, Hamrah P. Validity and reliability of a novel ocular pain assessment survey (OPAS) in quantifying and monitoring corneal and ocular surface pain. Ophthalmology. 2016;123(7):1458\u201368.","journal-title":"Ophthalmology"},{"issue":"Suppl 3","key":"1392_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.1753","volume":"22","author":"G Sharma","year":"2019","unstructured":"Sharma G, Naujoks C, Sloesen B, Goswami P, Patalano F. Patient-reported outcome measures in patients with chronic ocular surface pain: a literature review. Value Health. 2019;22(Suppl 3):S732.","journal-title":"Value Health"},{"issue":"11","key":"1392_CR28","first-page":"3029","volume":"33","author":"K Bisla","year":"1992","unstructured":"Bisla K, Tanelian DL. Concentration-dependent effects of lidocaine on corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1992;33(11):3029\u201333.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01392-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:27:15Z","timestamp":1781008035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01392-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01392-3","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to incorrect authors affiliation. Now, the authors affiliation has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anat Galor\u2014Alcon Bausch\u2009+\u2009Lomb, EyeCool (advisor), OKYO. Christopher Rapuano has nothing to disclose. Alice Epitropoulos has nothing to disclose. Jayne Weiss- Regeneron. Stephen Pflugfelder\u2014Alcon, Dompe, Kala, Kowa, Unfold. Preeya Gupta\u2014Azura, Alcon, Aldeyra, Abbvie, Bausch\u2009+\u2009Lomb, Dompe, HanAll Biopharma, Johnson & Johnson Vision, Kala, Mazado Inc, Nordic Pharma, Ocular Science, Oculis, Orasis, Sight Sciences, Science Based Health, Spyglass, Surface Ophthalmics, Tarsus, Tear Clear, Thea, Tissue Tech, Inc, Trukera, Viatris, Visionology, Vital Tears, Zeiss, EyeCool Therapeutics (advisor). Deepinder Dhaliwal\u2014Staar Surgical, Scope Ophthalmics, Thea, Tarsus, Bausch and Lomb, Aurion, Epion, Lenz, CSI Dry Eye. Laura Periman\u2014Alcon, Alderyra, Allergan\/Abbvie, Amgen, Azura, Bausch\u2009+\u2009Lomb, Bruder, Dompe, Eyedetec, Kala, Lumenis, Mallinckrodt, Myze, Nordic Pharma, Novartis, Nusight Medical, Olympic Ophthalmics, Quench Method, Science Based Health, Scope, Sun, Tarrsus, Thea, Versea, Viatris, Visant. Bonnie Henderson\u2014Eyecool Therapeutics (advisor). Thanh T. Nguyen has nothing to disclose. Chameen Samarawickrama has nothing to disclose. Helen Wu has nothing to disclose. Tomasz Stryjewski\u2014EyeCool Therapeutics (advisor). James A. Stefater\u2014EyeCool Therapeutics (advisor). Mark Hinds\u2014Financial Support: Azura Ophthalmics, Alcon, Alexion Pharmaceuticals, Pelthos Therapeutics, Eli Lilly and Company, EyeCool Technologies, Iolyx Therapeutics, Kiora Pharmaceuticals, Lubris Biopharma, Novo Nordisk Pharmaceuticals, Stuart. Therapeutics, Tarvo Biotherapeutics, TheiaNova. Consultant\/Contractor: Azura Ophthalmics, CooperVision, Eyecool Therapeutics, Kiora Pharmaceuticals, SynergEyes USA., Iolyx Therapeutics, Avant Insurance, Wotton Kearney, Remedy Medico-Legal. Pooja Bhindi has nothing to disclose. Cristos Ifantides\u2014Abbvie, Alcon, Bausch\u2009+\u2009Lomb, EyeCool Therapeutics (advisor), JnJ, Tarsus Pharmaceuticals, Trefoil.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and was approved by each study site\u2019s ethics committee. Study participants provided written informed consent prior to initiating any study procedure. The study was approved by St. Vincent\u2019s Hospital (Melbourne Australia) Human Research Ethics Committee (HREC) and registered with Clinical Trials.gov (NCT06479382).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}